RecruitingNCT03489278

Clinical Procedures to Support Research in ALS

Clinical Procedures to Support Research in ALS (CAPTURE-ALS)

Sponsor

University of Miami

Enrollment

1,200 participants

Start Date

Feb 15, 2018

Study Type

OBSERVATIONAL

Conditions

Amyotrophic Lateral Sclerosis Primary Lateral Sclerosis Progressive Muscular Atrophy ALS-Frontotemporal Dementia

Summary

The purpose of the Clinical Procedures To Support Research (CAPTURE) study is to utilize information collected in the medical record to learn more about a disease called amyotrophic lateral sclerosis (ALS) and related disorders.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with als-frontotemporal dementia, amyotrophic lateral sclerosis, and other related conditions. The study is currently recruiting participants at 11 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(11)

University of California, Irvine

Irvine, California, United States

Stanford University

Palo Alto, California, United States

California Pacific Medical Center

San Francisco, California, United States

University of Miami

Miami, Florida, United States

University of Kansas Medical Center

Kansas City, Kansas, United States

Hennepin County Medical Center

Minneapolis, Minnesota, United States

Columbia University

New York, New York, United States

Duke University

Durham, North Carolina, United States

Wake Forest University

Winston-Salem, North Carolina, United States

Providence Health & Services

Portland, Oregon, United States

University of Texas San Antonio Health Science Center

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03489278

Related Trials

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

NCT032251441 location

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

NCT0732200344 locations

A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT0757120010 locations

A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

NCT0757117410 locations

Analysis of Human ALS Tissues and Registry of ALS Patients

NCT050671791 location